Showing 15,781 - 15,800 results of 47,911 for search '(( 12 we decrease ) OR ( 50 ((((nn decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 1.11s Refine Results
  1. 15781

    Table_1_The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Ra... by Philip C. Spinella (5181788)

    Published 2020
    “…</p>Methods<p> This was a single center, double-blinded, randomized controlled trial (RCT) comparing placebo to a 2 g or 4 g intravenous TXA bolus dose in trauma patients with severe injury. …”
  2. 15782
  3. 15783

    Table_1_Campylobacter Colonization, Environmental Enteric Dysfunction, Stunting, and Associated Risk Factors Among Young Children in Rural Ethiopia: A Cross-Sectional Study From th... by Dehao Chen (4966207)

    Published 2021
    “…<p>Livestock farming provides a possible mechanism by which smallholder farmers can meet their household need for animal source foods (ASF), which may reduce the risk of stunting. …”
  4. 15784

    Different Phenotypes of the Two Chinese Probands with the Same c.889G>A (p.C162Y) Mutation in <i>COCH</i> Gene Verify Different Mechanisms Underlying Autosomal Dominant Nonsyndromi... by Qi Wang (22418)

    Published 2017
    “…The results presented bilateral sensorineural hearing loss with a decreasing pattern, involving the low frequencies. …”
  5. 15785
  6. 15786

    Data_Sheet_1_Comparison of Postnatal Growth Charts of Singleton Preterm and Term Infants Using World Health Organization Standards at 40–160 Weeks Postmenstrual Age: A Chinese Sing... by Li Zhang (8200)

    Published 2021
    “…The Z-scores for length/height, weight, and BMI of preterm infants relative to the WHO standards gradually decreased from 1.20, 1.13, and 0.74 at 40–44 weeks PMA to 0.67, 0.42, and 0.03 at 132–160 weeks PMA, respectively; Z-scores for HC of preterm infants rapidly decreased from 0.73 to 0.29 at 40–50 weeks PMA, and then fluctuated in the range of 0.08–0.23 at 50–160 weeks PMA. …”
  7. 15787

    Table_1_Neurophysiological and Neuroradiological Changes in Children With Chronic Kidney Disease.XLSX by Sameh A. Abd El Naby (9645500)

    Published 2020
    “…</p><p>Methods: The study included 50 patients with CKD admitted to a pediatric nephrology unit. …”
  8. 15788
  9. 15789

    Table_1_HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.xlsx by Seik-Soon Khor (7244753)

    Published 2021
    “…After multivariate analysis controlling for other confounding factors and comorbidities, HLA-A*11:01:01:01 [P = 3.34E-03, OR = 3.41 (1.50–7.73)], age at diagnosis [P = 1.29E-02, OR = 1.04 (1.01–1.07)] and sex at birth [P = 8.88E-03, OR = 2.92 (1.31–6.54)] remained significant. …”
  10. 15790

    Image_2_The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-depe... by James E. Blevins (11405813)

    Published 2024
    “…We hypothesized that GEP44 reduces energy intake and BW primarily through a GLP-1R dependent mechanism. To test this hypothesis, GLP-1R<sup>+/+</sup> mice and GLP-1R null (GLP-1R<sup>-/-</sup>) mice were fed a high fat diet for 4 months to elicit diet-induced obesity prior to undergoing a sequential 3-day vehicle period, 3-day drug treatment (5, 10, 20 or 50 nmol/kg; GEP44 vs the selective GLP-1R agonist, exendin-4) and a 3-day washout. …”
  11. 15791

    Image_1_The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-depe... by James E. Blevins (11405813)

    Published 2024
    “…We hypothesized that GEP44 reduces energy intake and BW primarily through a GLP-1R dependent mechanism. To test this hypothesis, GLP-1R<sup>+/+</sup> mice and GLP-1R null (GLP-1R<sup>-/-</sup>) mice were fed a high fat diet for 4 months to elicit diet-induced obesity prior to undergoing a sequential 3-day vehicle period, 3-day drug treatment (5, 10, 20 or 50 nmol/kg; GEP44 vs the selective GLP-1R agonist, exendin-4) and a 3-day washout. …”
  12. 15792
  13. 15793

    Transfection efficiency corrected <sup>3</sup>H-gemcitabine uptake in HEK293 (A), AsPC-1 (B), and MIA PaCa-2 (C) cells with or without transfection of hCNT3 cDNA. by Robert J. Paproski (282968)

    Published 2013
    “…Uptake values were corrected for transfection efficiency as described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056423#s2" target="_blank">methods</a> section. …”
  14. 15794
  15. 15795

    DataSheet1_Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatmen... by Ziqiang Li (247218)

    Published 2022
    “…</p><p>Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%–50%) in humans and rats, while CIP hardly changed circulating GA and PCA. …”
  16. 15796

    DataSheet2_Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatmen... by Ziqiang Li (247218)

    Published 2022
    “…</p><p>Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%–50%) in humans and rats, while CIP hardly changed circulating GA and PCA. …”
  17. 15797
  18. 15798

    Data_Sheet_1_Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis.docx by Renée J. H. A. Tillie (11264361)

    Published 2021
    “…Pfkfb3<sup>wt/wt</sup> and Pfkfb3<sup>fl/fl</sup> mice were fed a 0.25% cholesterol diet for 12 weeks. Pfkfb3<sup>fl/fl</sup> bone marrow-derived macrophages (BMDMs) showed 50% knockdown of Pfkfb3 mRNA. …”
  19. 15799

    Light-intensity dependence of net oxygen production and consumption, as measured with a membrane-inlet mass spectrometer (MIMS), of wild type <i>Synechocystis</i>, its ΔOx and ΔFlv... by R. Milou Schuurmans (798363)

    Published 2015
    “…Experiments with <i>Synechocystis</i> and its mutant derivatives were conducted at 18°C and <i>Chlorella</i> at 30°C. ●, oxygen evolution measured as an increase in the concentration of <sup>32</sup>O<sub>2</sub>; ◊, oxygen uptake measured as a decrease in the concentration of <sup>36</sup>O<sub>2</sub>; Δ, net rate of photosynthesis (i.e. rate of net oxygen evolution + rate of oxygen uptake). …”
  20. 15800

    DataSheet1_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

    Published 2024
    “…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”